Reneuron Share Discussion Threads

[rayrac] 10/7/2015 07:39

Everyone feeling they need a brain transplant?

Placing at a premium! Can't be bad?

[norbus] 09/7/2015 11:28

rf

R U saying they are holding the results till they sort the funding?

[yachtmaster2] 08/7/2015 15:28

Perhaps the shares will bounce a bit when they realease the jam tomorrow blag outlook statement. Think I will hang on a bit.

[yachtmaster2] 08/7/2015 15:22

OMG Rocket fuel. I didn't realise this. Do you think I should sell out now while I'm still in profit.

[norbus] 08/7/2015 14:58

rf

And what if there is a funding at 4.25? most are in sub 3, so if another #30m or so takes it to 10p who would complain?

[stewart_25] 08/7/2015 12:18

so you have no evidence anywhere?

[rocket fuel] 07/7/2015 17:03

don't worry stewart, i expect you and the rest of the deluded mug punter speculators will be the last to know!

[stewart_25] 07/7/2015 09:23

And where is this news rocket?

[rocket fuel] 07/7/2015 07:45

looks like the bucket shop brokers are busy selling their discounted shares and as usual the beloved shareholders have been kept in the dark.

mass dilution announcement soon anyone?

[madengland] 03/7/2015 09:49

Looking forwards to some more trial updates..../

[easwarareddy] 01/7/2015 09:45

Rising steadily. Hopefully will keep steadily rising

[madengland] 27/6/2015 19:41

Why don't you address the question and facts? Deramping pillock, filtered.

[rocket fuel] 27/6/2015 18:39

I fancy there are at least half a billion certs ready to be printed off in the 'rinse the rene holders out again' back office. imo they will be punting them out at 4p a pop if they are lucky and can get them out the back door sharpish for another swift £20m to keep the gravy train going another 18 months for the BoD and their friends in the city!

[madengland] 26/6/2015 18:09

More likely they are expecting a major fillip as results of trials build..... Then undoubtedly some funding, possibly open offer

[madengland] 26/6/2015 18:07

RF, give me your take on this• Neil has a huge stake and has been buying. He talks to management. Do you think he's committing money to lose it? Really? • 16M or so at interims, some increase in cash burn. Possibly 8.5M a year now?• preparing for production• results on trials looking healthy, great potential So tell me, just why would Mgt giveaway equity cheap at this stage?

[rocket fuel] 26/6/2015 11:42

monday or tuesday for results then chaps, could get messy if they don't. you have got to wonder why its taking three months to prepare the cash burn statement that could be totted up within 24 hrs of close of FY back at the end of march. lets face it they are not counting or calculating any revenues here are they? lol. its all about the on coming tsunami of rene confetti in the form of mass dilution once again that's about to hit you guys! enjoy.

[dogwalker] 26/6/2015 09:56

IC, today, think they're worth a 'hold'.

[norbus] 23/6/2015 11:31

RF

Getting close to where I got off the train a few years back; There is no doubt they are delivering progress; They are still cheap'ish if they deliver the stroke
and that is certainly on the cards; Others have in Parkinson and Alzheimer; danger of a retrace, but they have more than one horse running

[yachtmaster2] 22/6/2015 19:26

Anyone remember GEO. Bought them at 16p Sold at £34.00. They never made a penny. CEO ended up in jail. Place you bet take your chance or else forget about it. AIM and life is pretty much a lottery Rocketfuel. But you need to speculate to make decent money. Happy to hold!

[rocket fuel] 22/6/2015 18:06

as a matter of fact am having a right old laugh right now wondering if TMF might want to amend another one of their misleading articles again? a brokers assumption is not a confirmed company forecast nor an expectation of any given revenues. its all hypothetical!

[rocket fuel] 22/6/2015 17:33

N+1 Singer’s figures assume but The motley Fool article forecast and expected.


from TMF
However, looking ahead to financial year 2017, ReNeuron is forecast to post a pretax profit of £26m, as it is expected to see revenue increase from a very small amount to around £40m

[rocket fuel] 22/6/2015 17:12

N+1 Singer’s figures assume the company will take on partners for its lead drugs and have ReNeuron clocking up revenues of £40.3mln in fiscal 2017, leading to adjusted profit before tax of £26.2mln.

[elgordo] 22/6/2015 17:09

For fear of giving the impression I was providing support to Rf's position, I decided to find out the answer to my own question. See here, covering N+1 Singer's initiation of coverage in December 2014 (and apologies to other posters who presumably already covered this back when it was published) -

hxxp://www.proactiveinvestors.co.uk/companies/news/64421/reneuron-has-potential-to-establish-attractive-deals-75254.html

"The broker’s forecasts do not have the company making any revenues until the year to end-March 2017 but it notes that, with £16.1mln in cash at the end of September, the company is funded through to the third quarter of 2016.

By that time, the company’s CTX for stroke should be in phase III of clinical testing, CTX for critical limb ischaemia (CLI) should be in phase II, as should hRPC for retinitis pigmentosa (RP).

N+1 Singer’s figures assume the company will take on partners for its lead drugs and have ReNeuron clocking up revenues of £40.3mln in fiscal 2017, leading to adjusted profit before tax of £26.2mln.

Projected underlying earnings per share for fiscal 2017 of 1.6p put the stock on a price/earnings ratio of just 2.26p based on the current share price of 3.625p.

The broker’s 6.2p valuation of ReNeuron is based on potential income stream from its two current clinical development programmes: CTX targeting stroke and CTX targeting CLI.

It has not included hRPC for RP because this is still at an early stage of development, with the development drug not expected to enter the clinic until next year.

Assuming successful development, it expects CTX for stroke will be launched in 2020, though there is the potential for conditional approval in Japan prior to this.

Peak sales within five years of launch are put at an eye-popping £1.1bn, or thereabouts."

[rocket fuel] 22/6/2015 17:03

have really got to laugh at that motley fool article. the same idiots published a ramped up article on blinkx (BLNX) last year, the fools highlighted all their revs, profits and cash in bank in pounds sterling when in fact blinkx report in dollars. well, after a shedload of mug punters jumped on board I highlighted the mistake on the blnx bb here and after a few hrs of going viral around the financial blinks bb's the munter who initially released the article on TMF apologised and corrected his currency issues. lol, the stock has since fallen by more than 80%